Antisense Therapeutics Overview

  • Status
  • Public
  • Employees
  • 8
Employees
  • Stock Symbol
  • ANP
Stock Symbol
  • Share Price
  • $0.17
  • (As of Friday Closing)

Antisense Therapeutics General Information

Description

Antisense Therapeutics Ltd is a drug manufacturer. The company is engaged in research and development of novel antisense pharmaceuticals.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Stock Exchange
ASX
Primary Office
  • 6 Wallace Avenue
  • Toorak, Victoria 3142
  • Australia
+61 (03) 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Antisense Therapeutics Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.17 $0.17 $0.04 - $0.21 $95.7M 574M 1.43M

Antisense Therapeutics Financials Summary

In Thousands,
USD
TTM 31-Mar-2021 FY 2020 30-Jun-2020 FY 2019 30-Jun-2019 FY 2018 30-Jun-2018
EV 84,255 22,157 9,668 2,284
EBITDA (3,897) (2,149) (1,820)
Net Income (3,957) (2,105) (1,806)
Total Assets 3,678 2,590 3,528
Total Debt 93 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Antisense Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Antisense Therapeutics‘s full profile, request access.

Request a free trial

Antisense Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Antisense Therapeutics Ltd is a drug manufacturer. The company is engaged in research and development of novel antisense
Biotechnology
Toorak, Australia
8 As of 2018
0000
000000000 0000

000000

p ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dol
0000000000000
Seattle, WA
000 As of 0000
00000
0000 0000-00-00
00000000 00000

00000 00

ectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim
0000 000000000
San Diego, CA
000 As of 0000
00000
000000 - 000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Antisense Therapeutics Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Omeros Formerly VC-backed Seattle, WA 000 00000 00000000 00000
00000 000000000000 Formerly VC-backed San Diego, CA 000 00000 000000 - 000 00000
00000000 000000000 Corporate Backed or Acquired San Diego, CA 000 00000 000000&0
000000 00000000000 Formerly VC-backed San Diego, CA 000 00000 000000&0
000000000 000000 Formerly VC-backed Cambridge, MA 000 00000 00000000 00000
You’re viewing 5 of 10 competitors. Get the full list »

Antisense Therapeutics Executive Team (2)

Name Title Board Seat Contact Info
Mark Diamond President & Chief Executive Officer
Phillip Hains Chief Financial Officer & Company Secretary
To view Antisense Therapeutics’s complete executive team members history, request access »

Antisense Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial